Decera Clinical Education Oncology Podcast
Decera Clinical Education Oncology Podcast · Apr 13, 2026 · 33:13
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
In this episode, Dr Matthew Gubens and Dr Helena Yu discuss the evolving role of TROP2-directed therapies in non-small-cell lung cancer, with a focus on how antibody–drug conjugates (ADCs) fit into current treatment strategies, including
Get access to all of our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify.
Presenters:
Matthew Gubens, MD, MS, FASCO
Medical Director, Thoracic Medical Oncology
University of California, San Francisco
San Francisco, California
Helena Yu, MD
Professor of Medicine
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York
Link to full program:
https://bit.ly/41vAnfH
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Episodes: Decera Clinical Education Oncology Podcast